selected scholarly activity
-
academic article
- Low-Dose Hemibody Radiation, a Treatment Option for Recurrent Prostate Cancer: A Phase 2 Single-Arm Trial. Advances in Radiation Oncology. 8:101066-101066. 2023
- Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating 2 Ultrahypofractionated Regimens for Prostate Cancer. International Journal of Radiation Oncology Biology Physics. S0360-3016(22)03671-9. 2022
- Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial. The Lancet Oncology. 23:1308-1320. 2022
-
Salvage radiotherapy following
HiFU : An institutional series and literature review. Australasian Radiology Journal of Medical Imaging and Radiation Oncology. 66:847-852. 2022 - A systematic review of axillary nodal irradiation for the management of the axilla in patients with early-stage breast cancer. Surgical Oncology. 42:101754-101754. 2022
- Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415. JCO Clinical Cancer Informatics. 6:e2100188. 2022
- The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments. Clinical Genitourinary Cancer. 20:e25-e38. 2022
- Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline. Journal of Clinical Oncology. 39:3056-3082. 2021
- A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806). Clinical Genitourinary Cancer. 18:e410-e415. 2020
- Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer. Journal of the Canadian Urological Association. 14:123-130. 2020
- Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases. Asian Journal of Andrology. 22:437-437. 2020
- Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. The Lancet Oncology. 20:1531-1543. 2019
- Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415. Radiotherapy and Oncology. 135:19-24. 2019
- Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy. JAMA Oncology. 5:664-664. 2019
- Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. International Journal of Radiation Oncology Biology Physics. 102:287-295. 2018
- Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer. Jama Network Open. 1:e182081-e182081. 2018
- Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate. International Journal of Radiation Oncology Biology Physics. 99:90-93. 2017
- Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer. Journal of Clinical Oncology. 35:1884-1890. 2017
- Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer. Journal of Clinical Oncology. 34:2325-2332. 2016
- The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer. Technology in Cancer Research and Treatment. 15:171-178. 2016
- Biological Response of Positron Emission Tomography Scan Exposure and Adaptive Response in Humans. Dose-Response. 13:155932581561190-155932581561190. 2015
- 18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer. British Journal of Cancer. 112:1737-1743. 2015
- Locoregional Therapy of Locally Advanced Breast Cancer: A Clinical Practice Guideline. Current Oncology. 22:54-66. 2015
- Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828. Practical Radiation Oncology. 4:187-191. 2014
- Randomized Trial of Decongestive Lymphatic Therapy for the Treatment of Lymphedema in Women With Breast Cancer. Journal of Clinical Oncology. 31:3758-3763. 2013
- Systematic review: conservative treatments for secondary lymphedema. BMC Cancer. 12:6. 2012
- Intensity-modulated Radiotherapy in the Treatment of Breast Cancer. Clinical Oncology Comparative Haematology International. 24:488-498. 2012
- Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. Radiation Oncology. 6:144. 2011
- Conservative and dietary interventions for cancer-related lymphedema. Cancer. 117:1136-1148. 2011
- In Reply to Dr. Azria et al.. International Journal of Radiation Oncology Biology Physics. 75:1275-1276. 2009
- Radiation-Induced Lymphocyte Apoptosis to Predict Radiation Therapy Late Toxicity in Prostate Cancer Patients. International Journal of Radiation Oncology Biology Physics. 74:1424-1430. 2009
- Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial. Breast Cancer Research and Treatment. 110:337-342. 2008
- Current issues in the management of lymphedema in breast cancer patients.. Journal of Supportive Oncology. 4:392-393. 2006
- Cross-Border Referral for Early Breast Cancer: An Analysis of Radiation Fractionation Patterns. Current Oncology. 13:124-129. 2006
- The Importance of Reporting Patient Recruitment Details in Phase III Trials. Journal of Clinical Oncology. 24:843-845. 2006
- Local tumour control in women with carcinoma of the cervix treated with the addition of nitroimidazole agents to radiotherapy: a meta-analysis. British Journal of Radiology. 78:777-782. 2005
- Randomized Trial Comparing Iridium Implant Plus External-Beam Radiation Therapy With External-Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate. Journal of Clinical Oncology. 23:1192-1199. 2005
- Unforeseen complication of brachytherapy. CMAJ. 170:1209-1210. 2004
-
conference paper
- Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415. PLoS ONE. 2021
- Investigation Into the Feasibility of Having Uniform Compliance Dosimetric Criteria Across Radiation Therapy Treatment Modalities for NRG Oncology/RTOG 0938 by Using Machine Learning. International Journal of Radiation Oncology Biology Physics. E230-E231. 2016
- NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results. International Journal of Radiation Oncology Biology Physics. S2-S3. 2016
- Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP).. Journal of Clinical Oncology. 27-27. 2016
- NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer. International Journal of Radiation Oncology Biology Physics. 3-4. 2016
- Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer. International Journal of Radiation Oncology Biology Physics. 2-2. 2016
- Global Radiation Oncology Elective in Teaching CanMEDS Competencies. International Journal of Radiation Oncology Biology Physics. E377-E377. 2015
- Identifying Risk Factors for Locoregional Recurrence Following Postmastectomy Radiation Therapy. International Journal of Radiation Oncology Biology Physics. S251-S251. 2012
- Positron emission tomography/computed tomography (PET/CT) for the diagnosis of recurrent cancer (PETREC): A multicenter, prospective cohort study.. Journal of Clinical Oncology. 2012
- An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.. Journal of Clinical Oncology. 2011
- DELTA: A Randomized Trial of Decongestive Lymphatic Therapy for Women with Lymphedema following Treatment for Breast Cancer. International Journal of Radiation Oncology Biology Physics. S53-S53. 2009
- LDR Prostate Brachytherapy: Dosimetric Evaluation of Stabilizing Needles and Seminal Vesicle Implants. International Journal of Radiation Oncology Biology Physics. S353-S353. 2009
- 14 Randomized Trial Comparing Iridium Plus External-Beam Radiation Therapy with External-Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate. Radiotherapy and Oncology. S5-S5. 2005
- Po-Poster - 29: Radiation-induced apoptosis of lymphocytes to predict late toxicity from radiotherapy. Medical Physics. 2415-2415. 2005
- Arm lymphedema in breast cancer patients: Is it always related to treatment. International Journal of Radiation Oncology Biology Physics. S402-S402. 2004
- Local tumor control in women with carcinoma of the cervix treated with the addition of nitroimidazole agents to radiotherapy: A meta-analysis. Radiology. 599-599. 2002